Validation of the national eye institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3354-3359

  Orr, Peggy ^a   Rentz, Anne M ^b   Margolis, Mary Kay ^b   Revicki, Dennis A ^b   Dolan, Chantal M ^c   Colman, Shoshana ^c   Fine, Jennifer T ^c   Bressler, Neil M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; EVOKED VISUAL RESPONSE; EYE EXAMINATION; EYE REFRACTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE 25; PRIORITY JOURNAL; PSYCHOMETRY; READING; RELIABILITY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; VALIDITY; VISUAL ACUITY; CLINICAL TRIAL; DISABILITY; FLUORESCENCE ANGIOGRAPHY; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; OPHTHALMOSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; RETINA MACULA DEGENERATION; SICKNESS IMPACT PROFILE; UNITED STATES; VALIDATION STUDY;

AGED; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; MALE; NATIONAL EYE INSTITUTE (U.S.); OPHTHALMOSCOPY; QUESTIONNAIRES; READING; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; UNITED STATES; VISUAL ACUITY;

EID: 80051570440     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5645     Document Type: Article

References (26)

1. Bass EB, Marsh MJ, Mangione CM, et al. Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization-The Submacular Surgery Trials Vision Preference Value Scale: SST report no. 6. Arch Ophthalmol. 2004;122:1856-1867.
2. Childs AL, Bressler NM, Bass EB, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. Ophthalmology. 2004; 111:2007-2014.
3. Clemons TE, Chew EY, Bressler SB, McBee W. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report no. 10. Arch Ophthalmol. 2003;121: 211-217.
4. Dong LM, Childs AL, Mangione CM, et al. Health-and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol. 2004;138:91-108.
5. Hawkins BS, Miskala PH, Bass EB, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic, II: quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST report no. 10. Arch Ophthalmol. 2004;122:1616-1628.
6. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol. 2004;122:758-766.
7. Miskala PH, Hawkins BS, Mangione CM, et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization-SST report no. 1. Arch Ophthalmol. 2003;121:531-539.
8. Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of visionrelated function in patients with age-related macular degeneration. Ophthalmology. 2002;109:720-729.
9. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514-520.
10. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355: 1419-1431.
11. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
12. Regillo CD, Brown DM, Abraham P, et al. Randomized, doublemasked, sham-controlled trial of ranibizumab for neovascular agerelated macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008;145:239-248.
13. Mangione CM. NEI VFQ-25 Scoring Algorithm. Rockville, MD: National Eye Institute; 2000. http://www.nei.nih.gov/resources/ visionfunction/manual_cm2000.pdf. Accessed March 9, 2010.
14. Revicki DA, Irwin D, Reblando J, Simon GE. The accuracy of self-reported disability days. Med Care. 1994;32:401-404.
15. Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
16. Submacular Surgery Trials (SST) Manual of Procedures, June 1,
17. NTIS accession no. PB98-166648. Springfield, VA: National Technical Information Service; 1998.
18. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vision Sci. 1988;2:187-199.
19. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
20. Hays RD, Revicki DA. Reliability and validity (including responsiveness). In: Fayers P, Hays R, eds. Assessing Quality of Life in Clinical Trials. 2nd ed. New York: Oxford University Press; 2005: 25-39.
21. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
22. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
23. Matchar DB, Suner IJ, Samsa GP, McCrory DC, Cline K, Lee PP. Measuring quality of life for patients with age-related macular degeneration: AHQR Technology Assessment Program. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2006.
24. Finger RP, Fleckenstein M, Holz FG, Scholl HP. Quality of life in age-related macular degeneration: a review of available visionspecific psychometric tools. Qual Life Res. 2008;17:559-574.
25. Maguire M. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology. 2004;111:1307-1316.
26. Gill TM, Desai MM, Gahbauer EA, Holford TR, Williams CS. Restricted activity among community-living older persons: incidence, precipitants, and health care utilization. Ann Intern Med. 2001; 135:313-321.